《广州医药》
点击关注官方服务号追踪稿件状态

【重要服务提醒】《广州医药》杂志服务号已上线稿件查询功能

各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。

操作方式

微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。

《广州医药》编辑部

广州医药杂志服务号
您的位置: 首页 > 2023年6月 第54卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

无乳链球菌感染性心内膜炎并急性肝衰竭1例

Streptococcus agalactiae infective endocarditis with acute liver failure

来源期刊: 广州医药 | 52-55 发布时间:2023-07-27 收稿时间:2025/11/13 18:33:31 阅读量:100
作者:
关键词:
无乳链球菌感染性心内膜炎急性肝衰竭
Streptococcus agalactiaeinfective endocarditisacute liver failure
DOI:
10.3969/j.issn.1000-8535.2023.06.009
收稿时间:
2022-09-20 
修订日期:
 
接收日期:
 
引用总数:
2  
目的 探讨无乳链球菌感染性心内膜炎的临床特点和治疗效果。方法 回顾性分析我院收治的1例无乳链球菌感染性心内膜炎合并急性肝衰竭患者的临床表现、诊疗经过及预后。结果 经过积极抗感染、血浆置换和体外循环下赘生物清除、瓣膜置换手术治疗,术后继续予抗感染、抗凝等治疗,患者脏器功能恢复良好,取得了良好的治疗效果,并顺利出院。结论 无乳链球菌感染性心内膜炎可引起急性心力衰竭、急性肝衰竭、急性肾衰竭等多脏器功能不全,合理把握手术时机和准确评估围术期风险有助于提高急危重症感染性心内膜炎患者的救治率。
Objective To explore the clinical characteristics and treatment of infective endocarditis caused by Streptococcus agalactiae.Methods Clinical data and treatment details of a patient with Streptococcus agalactiae endocarditis and acute liver failure admitted to our hospital was analyzed retrospectively.Results After strict anti-biotic therapy and plasmapheresis,the patient received the vegetative removal and valve replacement and finally successfully recovered.Conclusions The diagnosis and treatment of this case suggests that Streptococcus agalactiae infective endocarditis can cause multiple organ dysfunction such as acute heart,liver and renal failure.Optimal timing of surgery and accurate benefits-risk assessment is helpful to improve the prognosis of patients with acute and severe infective endocarditis.
1、 SAMBOLA A,MIRO J M,TORNOS M P,et al.Streptococcus agalactiae infective endocarditis:analysis of 30 cases and review of the literature,1962-1998[J].Clin Infect Dis,2002,34(12):1576-1584. SAMBOLA A,MIRO J M,TORNOS M P,et al.Streptococcus agalactiae infective endocarditis:analysis of 30 cases and review of the literature,1962-1998[J].Clin Infect Dis,2002,34(12):1576-1584.
2、 ORAVEC T,ORAVEC S A,LEIGH J,et al.Streptococcus agalactiae infective endocarditis in Canada:a multicenter retrospective nested case control analysis[J].BMC Infect Dis,2022,22(1):18. ORAVEC T,ORAVEC S A,LEIGH J,et al.Streptococcus agalactiae infective endocarditis in Canada:a multicenter retrospective nested case control analysis[J].BMC Infect Dis,2022,22(1):18.
3、 刘婧娴,陈星月,赵晶,等.非妊娠成人无乳链球菌感染临床特点及分子流行病学研究进展[J].检验医学,2022,37(8):793-797. 刘婧娴,陈星月,赵晶,等.非妊娠成人无乳链球菌感染临床特点及分子流行病学研究进展[J].检验医学,2022,37(8):793-797.
4、 WANG A,GACA J G,CHU V H.Management considerations in infective endocarditis:A review[J].JAMA,2018,320(1):72-83. WANG A,GACA J G,CHU V H.Management considerations in infective endocarditis:A review[J].JAMA,2018,320(1):72-83.
5、 HUGGINS J P,HOHMANN S,DAVID M Z.Candida infective endocarditis:A retrospective study of patient characteristics and risk factors for death in 703 United States cases,2015-2019[J].Open Forum Infect Dis,2021,8(2):ofaa628. HUGGINS J P,HOHMANN S,DAVID M Z.Candida infective endocarditis:A retrospective study of patient characteristics and risk factors for death in 703 United States cases,2015-2019[J].Open Forum Infect Dis,2021,8(2):ofaa628.
6、 LIN P M F,CHOW S C Y,NG S W Y,et al.Acute liver failure with extreme hyperbilirubinemia secondary to endocarditis-related severe mitral and tricuspid regurgitation:a challenge and an opportunity for surgeons[J].J Thorac Dis,2018,10(2):1067-1071. LIN P M F,CHOW S C Y,NG S W Y,et al.Acute liver failure with extreme hyperbilirubinemia secondary to endocarditis-related severe mitral and tricuspid regurgitation:a challenge and an opportunity for surgeons[J].J Thorac Dis,2018,10(2):1067-1071.
7、 DIAB M,SPONHOLZ C,von LOEFFELHOLZ C,et al.Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients[J].Infection,2017,45(6):857-866. DIAB M,SPONHOLZ C,von LOEFFELHOLZ C,et al.Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients[J].Infection,2017,45(6):857-866.
8、 GARCIA GRANJA P E,LOPEZ J,VILACOSTA I,et al.Prognostic impact of cardiac surgery in left-sided infective endocarditis according to risk profile[J].Heart,2021,107(24):1987-1994. GARCIA GRANJA P E,LOPEZ J,VILACOSTA I,et al.Prognostic impact of cardiac surgery in left-sided infective endocarditis according to risk profile[J].Heart,2021,107(24):1987-1994.
9、 HE P C,WEI X B,LUO S N,et al.Risk prediction in infective endocarditis by modified MELD-XI score[J].Eur J Clin Microbiol Infect Dis,2018,37(7):1243-1250. HE P C,WEI X B,LUO S N,et al.Risk prediction in infective endocarditis by modified MELD-XI score[J].Eur J Clin Microbiol Infect Dis,2018,37(7):1243-1250.
10、 GATTI G,BENUSSI B,GRIPSHI F,et al.A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system[J].Infection,2017,45(4):413-423. GATTI G,BENUSSI B,GRIPSHI F,et al.A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system[J].Infection,2017,45(4):413-423.
11、 GACA J G,SHENG S,DANESHMAND M A,et al.Outcomes for endocarditis surgery in North America:A simplified risk scoring system[J].J Thorac Cardiovasc Surg,2011,141(1):98-106. GACA J G,SHENG S,DANESHMAND M A,et al.Outcomes for endocarditis surgery in North America:A simplified risk scoring system[J].J Thorac Cardiovasc Surg,2011,141(1):98-106.
12、 CAHILL T J,BADDOUR L M,HABIB G,et al.Challenges in infective endocarditis[J].J Am Coll Cardiol,2017,69(3):325-344. CAHILL T J,BADDOUR L M,HABIB G,et al.Challenges in infective endocarditis[J].J Am Coll Cardiol,2017,69(3):325-344.
13、 NAKATANI S,OHARA T,ASHIHARA K,et al.JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis[J].Circ J,2019,83(8):1767-1809. NAKATANI S,OHARA T,ASHIHARA K,et al.JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis[J].Circ J,2019,83(8):1767-1809.
14、 REZAR R,LICHTENAUER M,HAAR M,et al.Infective endocarditis-A review of current therapy and future challenges[J].Hellenic J Cardiol,2021,62(3):190-200. REZAR R,LICHTENAUER M,HAAR M,et al.Infective endocarditis-A review of current therapy and future challenges[J].Hellenic J Cardiol,2021,62(3):190-200.
15、 刘鑫裴,苗齐.活动期感染性心内膜炎的外科治疗:进展与挑战[J].中国科学:生命科学,2021,51(8):970-978. 刘鑫裴,苗齐.活动期感染性心内膜炎的外科治疗:进展与挑战[J].中国科学:生命科学,2021,51(8):970-978.
1、王宽.奶牛乳房炎源性无乳链球菌流行菌株全基因组测序及其致病性研究[D].云南农业大学,2024.DOI:10.27458/d.cnki.gynyu.2024.000619. 王宽.奶牛乳房炎源性无乳链球菌流行菌株全基因组测序及其致病性研究[D].云南农业大学,2024.DOI:10.27458/d.cnki.gynyu.2024.000619.
2、任小艳,王秀君,樊艳婷.降钙素原、心肌肌钙蛋白与感染性心内膜炎患者预后的关系[J].国际医药卫生导报,2025,31(12):2002-2006. 任小艳,王秀君,樊艳婷.降钙素原、心肌肌钙蛋白与感染性心内膜炎患者预后的关系[J].国际医药卫生导报,2025,31(12):2002-2006.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录